U.S. Food and Drug Administration

Featured

Lung Illnesses Associated with Use of Vaping Products

Information for the Public, FDA Actions, and Recommendations

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

composite image showing concept of FDA research and technology

FDA’s Technology Modernization Action Plan

The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Nov 08

FDA approves first therapy to treat patients with rare blood disorder

Nov 06

Statement on the agency’s efforts to protect patients through postmarket drug safety surveillance practices

More Press Announcements

Newsroom Meetings Testimony Speeches

Nov 11

Taher Voluntarily Recalls Veggie & Ranch Cups With Cauliflower Because of Possible Health Risk

Food & Beverages

Nov 08

Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity

Drugs

Nov 08

American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity

Drugs

FDA Principal Deputy Commissioner Dr. Amy Abernethy reflects on the importance of incorporating patient perspectives into decisions about new and developing therapies.

Patient Perspective Is Vital to FDA's Work

FDA considers patients the real experts when it comes to their health conditions, as illustrated in the recent rare disease disorder summit.

collage of three separate images including a smiling young cancer patient with a scarf around her head, a tired or concerned nurse leaning against a wall pressing her fingers to her forehead, and a closeup of a syringe drawing clear liquid from a vial

To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality

Drug manufacturers with very high reliability usually have a mature quality management system — purchasers should have the ability to readily identify them.

Info-graphic that reads: Netting Results Through Strengthened Enforcement, FY 2019, 257 arrests (249 domestic, 8 foreign), 239 convictions, $2.3 billion in foreign forfeitures, fines and restitution, and 4,229 domain name seizures

Expanding Criminal Enforcement Operations Globally to Protect Public Health

FDA’s inspections, investigations, and law enforcement operations are led by FDA's Office of Regulatory Affairs.

Nov 14